Search

everythinglearnresearchcommunity

for

Search:↓

The microneedle patches effectively treat allergic conjunctivitis with controlled, sustained release of medication.

The new hyaluronic acid gel is as safe and effective for lip enhancement as the existing product.

Using Excimer light with topical steroids is the most effective treatment for alopecia areata.

The document discusses a special exam case for formulating and using systemic therapy named Athena.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

Understanding cellular interactions in VCA may lead to better treatments and reduce rejection.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

AI and new therapies show promise in medicine, especially for cancer and regenerative treatments.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Advancements in skin treatment and wound healing include promising gene therapy, 3D skin models, and potential new therapies.

The 1298CC genotype in RA patients leads to higher methotrexate toxicity, while the 1298AA genotype results in better treatment response.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

A woman with rheumatoid arthritis had a unique type of scarring hair loss not caused by infection, requiring early treatment to avoid permanent hair loss.

The new wound dressing improves healing and tissue repair better than conventional dressings.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

The EG7 foam dressing improved wound healing and reduced inflammation better than other treatments.

The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.

CFx-δ2 from stem cells helps heal burn wounds faster.

Upadacitinib effectively treated a patient with multiple inflammatory conditions.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Biosimilars lower costs but don't significantly improve access.

A new type of amniotic tissue graft improves wound healing better than other grafts.

Upadacitinib improved multiple immune-related conditions in one patient.

New techniques and materials improve sternum reconstruction and patient quality of life.

The patch effectively promotes hair growth for alopecia areata without pain.

BlastX helps heal uninfected wounds but doesn't improve healing in infected ones.

Combining TRA and latanoprost is most effective for treating localized alopecia areata.